as on February 9, 2026 at 9:31 pm IST
Day's Low
5.39%
Downside
52 Week's Low
52 Week's High
12.31%
Downside
32.00%
Upside
as on February 9, 2026 at 4:01 pm IST
Market Cap
₹471.23 Cr
Return on Equity (ROE)
20.25
PE Ratio (TTM)
0Return on capital employed (ROCE)
27.18
Beta (LTM)
0.78
P/B Ratio
2.6
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-8.91
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Jenburkt Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 471.23 | 32.21% | 0.00 | 32 | 151 | |
| NA | 79.75 | 46.88% | 0.70 | 1 | 45 | |
| NA | 19.17 | -12.87% | 0.82 | 3 | 168 | |
| NA | 3,308.55 | 380.28% | 0.76 | 8 | 1 | |
| NA | 68.45 | -0.02% | 0.00 | 7 | 50 |
Get share price movements and forecasts by analysts on Jenburkt Pharma .
Source: S&P Global Market Intelligence
Search interest for Jenburkt Pharmaceuticals Ltd Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:5% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Jenburkt Pharma .
Jenburkt Pharmaceuticals Ltd’s net profit fell -8.91% since last year same period to ₹5.93Cr in the Q3 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -41.63% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹18.00 per share on 20 May 2025 - translating a dividend yield of 3.13%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Jenburkt Pharma stock has moved up by 2.9%
Retail Holding Up
![]()
Retail Investor have increased holdings from 53.22% to 53.24% in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 155.8% return, outperforming this stock by 89.7%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.4% return, outperforming this stock by 25.7%
Promoter Holding Down
![]()
Promoters have decreased holdings from 46.66% to 46.65% in Dec 2025 quarter
| Organisation | Jenburkt Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Ashish U Bhuta |
| E-voting on shares | Click here to vote |
Jenburkt Pharma share price today stands at ₹1068.2 as on at the close of the market. Jenburkt Pharma share today touched a day high of ₹1068.2 and a low of ₹1010.65.
Jenburkt Pharma touched a 52 week high of ₹1410 and a 52 week low of ₹936.7. Jenburkt Pharma share price today i.e. is closed at ₹1068.2, which is -24.24% down from its 52 week high and 14.04% up from its 52 week low.
Jenburkt Pharma market capitalisation is ₹471.23 Cr as on .
To buy Jenburkt Pharma shares, you need to follow these steps:
Jenburkt Pharma trading volume is 2,679.00 as on . This means that 2,679.00 shares of Jenburkt Pharma were bought and sold on the stock market during today's trading session.